Disclosures for "The Utilization of In Vitro Human-on-a-Chip Neural Networks to Assess Neurocognitive Impairment for Drug Safety and Efficacy"
-
Dr. Autar has received personal compensation for serving as an employee of Hesperos, inc.. Dr. Autar has stock in Hesperos, inc..
-
The institution of Xiufang Guo has received research support from NIH. The institution of Xiufang Guo has received research support from UCF/Office of Research & Comercialization/Florida High Tech Corridor Council (FHTCC) .
-
Mr. Bogen has nothing to disclose.
-
Dr. Long has received personal compensation for serving as an employee of Hesperos, Inc.. Dr. Long has stock in Hesperos, Inc..
-
Dr. Turgeon has stock in GalenusRx.
-
Dr. Morgan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MindImmun.
-
James Hickman has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Hesperos, Inc.. James Hickman has stock in Hesperos, Inc.. The institution of James Hickman has received research support from Hesperos, Inc.. James Hickman has received intellectual property interests from a discovery or technology relating to health care. James Hickman has a non-compensated relationship as a Chief Scientist with Hesperos, Inc. that is relevant to AAN interests or activities.